Cargando…

The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control

BACKGROUND: Inflammatory bowel disease (IBD) is a systemic inflammatory disease and is classified as Crohn’s disease (CD) or ulcerative colitis (UC) depending on the extent of gastrointestinal tract involvement. IBD can be associated with extraintestinal findings, such as fever, weight loss, arthral...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Luis Filpe, Bergamo, Vinicius Campos, Conti, Marina Lourenco, Fares, Nikoly Tigani, Costa, Livia Almeida, Ambrogini, Orlando, de Moraes, Nilva Simeren Bueno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683555/
https://www.ncbi.nlm.nih.gov/pubmed/31406581
http://dx.doi.org/10.1186/s40942-019-0168-9
_version_ 1783442119174651904
author Nakayama, Luis Filpe
Bergamo, Vinicius Campos
Conti, Marina Lourenco
Fares, Nikoly Tigani
Costa, Livia Almeida
Ambrogini, Orlando
de Moraes, Nilva Simeren Bueno
author_facet Nakayama, Luis Filpe
Bergamo, Vinicius Campos
Conti, Marina Lourenco
Fares, Nikoly Tigani
Costa, Livia Almeida
Ambrogini, Orlando
de Moraes, Nilva Simeren Bueno
author_sort Nakayama, Luis Filpe
collection PubMed
description BACKGROUND: Inflammatory bowel disease (IBD) is a systemic inflammatory disease and is classified as Crohn’s disease (CD) or ulcerative colitis (UC) depending on the extent of gastrointestinal tract involvement. IBD can be associated with extraintestinal findings, such as fever, weight loss, arthralgia, and mucocutaneous lesions, as well as hepatic, renal and ophthalmological involvement. Clinical parameters and colonoscopy are used to establish the criteria for controlled or non-controlled disease and subsequent definition of treatment. Our objective in the present study was to compare the area of the foveal avascular zone (FAZ) in patients with a diagnosis of IBD during remission and active disease. METHODS: 144 eyes of 72 patients with IBD were evaluated via a complete ophthalmological exam. Fundus photography and optical coherence tomography/angiography (OCT/OCTA) were performed with a Topcon Triton. The macula and posterior pole were evaluated by binocular indirect ophthalmoscopy and fundus biomicroscopy. The area of the FAZ was determined via manual delimitation of superficial retinal vascular layers from OCTA with image6.net software. To establish disease activity, we considered the Mayo Score, fecal calprotectin levels, colonoscopy results and clinical parameters. All retinal parameters were evaluated in a blinded manner. Means were compared between groups using the Mann–Whitney test. RESULTS: The participants had a mean age of 42.26 years and included 28 males (38.88%) and 44 females (61.11%). Among the participants, 37 had a diagnosis of CD (51.38%), and 35 had a diagnosis of UC (48.61%). Twenty-five patients (34.72%) had active disease, and 47 (65.27%) were in remission. The area of the FAZ did not differ significantly between the CD and UC groups (p = 0.91 for the right eye and p = 0.76 for the left eye) but did differ significantly between the remission and active disease groups (p = 0.01 for the right eye and p = 0.02 for the left eye). DISCUSSION: Our study is the first to evaluate the area of the FAZ in patients with IBD via swept-source OCTA. The area of the FAZ did not differ significantly in either eye between the CD and UC groups. However, patients classified as having active disease according to clinical parameters and colonoscopy presented a significant decrease in the area of the FAZ compared with patients in remission. The area of the FAZ is an ophthalmological parameter that can be obtained non-invasively and is increased in ischemic diseases such as diabetic retinopathy. The FAZ may decrease due to vascular engorgement or increased systemic inflammation. This parameter can be used to help determine whether a patient is in remission or active IBD, thus potentially reducing the need for invasive exams during disease follow-up.
format Online
Article
Text
id pubmed-6683555
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66835552019-08-12 The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control Nakayama, Luis Filpe Bergamo, Vinicius Campos Conti, Marina Lourenco Fares, Nikoly Tigani Costa, Livia Almeida Ambrogini, Orlando de Moraes, Nilva Simeren Bueno Int J Retina Vitreous Original Article BACKGROUND: Inflammatory bowel disease (IBD) is a systemic inflammatory disease and is classified as Crohn’s disease (CD) or ulcerative colitis (UC) depending on the extent of gastrointestinal tract involvement. IBD can be associated with extraintestinal findings, such as fever, weight loss, arthralgia, and mucocutaneous lesions, as well as hepatic, renal and ophthalmological involvement. Clinical parameters and colonoscopy are used to establish the criteria for controlled or non-controlled disease and subsequent definition of treatment. Our objective in the present study was to compare the area of the foveal avascular zone (FAZ) in patients with a diagnosis of IBD during remission and active disease. METHODS: 144 eyes of 72 patients with IBD were evaluated via a complete ophthalmological exam. Fundus photography and optical coherence tomography/angiography (OCT/OCTA) were performed with a Topcon Triton. The macula and posterior pole were evaluated by binocular indirect ophthalmoscopy and fundus biomicroscopy. The area of the FAZ was determined via manual delimitation of superficial retinal vascular layers from OCTA with image6.net software. To establish disease activity, we considered the Mayo Score, fecal calprotectin levels, colonoscopy results and clinical parameters. All retinal parameters were evaluated in a blinded manner. Means were compared between groups using the Mann–Whitney test. RESULTS: The participants had a mean age of 42.26 years and included 28 males (38.88%) and 44 females (61.11%). Among the participants, 37 had a diagnosis of CD (51.38%), and 35 had a diagnosis of UC (48.61%). Twenty-five patients (34.72%) had active disease, and 47 (65.27%) were in remission. The area of the FAZ did not differ significantly between the CD and UC groups (p = 0.91 for the right eye and p = 0.76 for the left eye) but did differ significantly between the remission and active disease groups (p = 0.01 for the right eye and p = 0.02 for the left eye). DISCUSSION: Our study is the first to evaluate the area of the FAZ in patients with IBD via swept-source OCTA. The area of the FAZ did not differ significantly in either eye between the CD and UC groups. However, patients classified as having active disease according to clinical parameters and colonoscopy presented a significant decrease in the area of the FAZ compared with patients in remission. The area of the FAZ is an ophthalmological parameter that can be obtained non-invasively and is increased in ischemic diseases such as diabetic retinopathy. The FAZ may decrease due to vascular engorgement or increased systemic inflammation. This parameter can be used to help determine whether a patient is in remission or active IBD, thus potentially reducing the need for invasive exams during disease follow-up. BioMed Central 2019-08-06 /pmc/articles/PMC6683555/ /pubmed/31406581 http://dx.doi.org/10.1186/s40942-019-0168-9 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Nakayama, Luis Filpe
Bergamo, Vinicius Campos
Conti, Marina Lourenco
Fares, Nikoly Tigani
Costa, Livia Almeida
Ambrogini, Orlando
de Moraes, Nilva Simeren Bueno
The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control
title The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control
title_full The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control
title_fullStr The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control
title_full_unstemmed The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control
title_short The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control
title_sort retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683555/
https://www.ncbi.nlm.nih.gov/pubmed/31406581
http://dx.doi.org/10.1186/s40942-019-0168-9
work_keys_str_mv AT nakayamaluisfilpe theretinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT bergamoviniciuscampos theretinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT contimarinalourenco theretinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT faresnikolytigani theretinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT costaliviaalmeida theretinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT ambroginiorlando theretinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT demoraesnilvasimerenbueno theretinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT nakayamaluisfilpe retinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT bergamoviniciuscampos retinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT contimarinalourenco retinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT faresnikolytigani retinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT costaliviaalmeida retinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT ambroginiorlando retinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol
AT demoraesnilvasimerenbueno retinalfovealavascularzoneasasystemicbiomarkertoevaluateinflammatoryboweldiseasecontrol